JOHN Q. STAUFFER, M.D.; MICHAEL H. HUMPHREYS, M.D.; G. JOHN WEIR, M.D., F.A.C.P.
Urinary oxalate excretion was measured in 11 patients with inflammatory bowel disease involving the terminal ileum. Group A consisted of six patients with minimal or no resection of terminal ileum and group B of six patients with resections greater than 30 cm. Basal urinary oxalate excretion was normal in group A but was significantly elevated in group B. After treatment with oral cholestyramine, a drug known to bind bile salts, urinary oxalate excretion fell promptly in group B to within the normal range but remained unchanged in group A. Five of six patients in group B had severe, explosive, watery diarrhea, which was dramatically reversed by cholestyramine. Hyperoxaluria in two patients was reversed when oxalate was removed from the diet, and in-vitro studies showed that cholestyramine binds oxalic acid. These data suggest that the mechanism of acquired hyperoxaluria in patients with ileal resection is related to enhanced absorption of dietary oxalate.
STAUFFER JQ, HUMPHREYS MH, WEIR GJ. Acquired Hyperoxaluria with Regional Enteritis After Ileal Resection: Role of Dietary Oxalate. Ann Intern Med. ;79:383–391. doi: 10.7326/0003-4819-79-3-383
Download citation file:
Published: Ann Intern Med. 1973;79(3):383-391.
Gastroenterology/Hepatology, Inflammatory Bowel Disease, Nephrology.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use